How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/follicular-non-hodgkin-s-lymphoma.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Follicular non-Hodgkin's lymphoma — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Follicular non-Hodgkin's lymphoma (disease) competitive landscape: 10 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

10 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Follicular non-Hodgkin's lymphoma, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Copiktra	DUVELISIB	Secura		Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform	2018-01-01
Treanda	BENDAMUSTINE	Baxter	Alkylating Drug	Histone deacetylase 6	2008-01-01
Doxorubicin Hydrochloride	doxorubicin	Pfizer	Anthracycline Topoisomerase Inhibitor	Aurora kinase A	1974-01-01
Liposomal Doxorubicin	liposomal-doxorubicin	Pfizer	doxorubicin	72 kDa type IV collagenase	1974-01-01
Blenoxane	BLEOMYCIN	Bristol-Myers Squibb	Cytoprotective Agent	Aspartyl/asparaginyl beta-hydroxylase	1973-01-01
Oncovin	Vincristine Sulfate	Pfizer Inc.	Vinca Alkaloid	Canalicular multispecific organic anion transporter 1	1963-01-01
Oncovin	vincristine	Pfizer Inc.	Vinca Alkaloid	Canalicular multispecific organic anion transporter 1	1963-01-01
Decadron	dexamethasone	Generic (originally Merck)	Corticosteroid [EPC]	Annexin A1, Interleukin-4, Androgen receptor	1958-10-30
Medrol	methylprednisolone	Generic (originally Upjohn/Pfizer)	Glucocorticoid (corticosteroid)	Annexin A1, Short transient receptor potential channel 5, Glucocorticoid receptor	1957-10-01
Leukeran	CHLORAMBUCIL	Waylis	Alkylating Drug [EPC]	Cathepsin D	1957-01-01

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

· 3 drugs in Follicular non-Hodgkin's lymphoma
University of Colorado, Denver · 2 drugs in Follicular non-Hodgkin's lymphoma
Generic (originally Schering) · 2 drugs in Follicular non-Hodgkin's lymphoma
Pfizer · 2 drugs in Follicular non-Hodgkin's lymphoma
Pfizer Inc. · 2 drugs in Follicular non-Hodgkin's lymphoma
Generic (originally Merck) · 1 drug in Follicular non-Hodgkin's lymphoma
Generic (originally Upjohn/Pfizer) · 1 drug in Follicular non-Hodgkin's lymphoma
Hannover Medical School · 1 drug in Follicular non-Hodgkin's lymphoma
Johann Wolfgang Goethe University Hospital · 1 drug in Follicular non-Hodgkin's lymphoma
Leiden University Medical Center · 1 drug in Follicular non-Hodgkin's lymphoma
Meir Medical Center · 1 drug in Follicular non-Hodgkin's lymphoma
Secura · 1 drug in Follicular non-Hodgkin's lymphoma

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Follicular non-Hodgkin's lymphoma:

Cite this brief

Drug Landscape (2026). Follicular non-Hodgkin's lymphoma — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/follicular-non-hodgkin-s-lymphoma. Accessed 2026-06-10.

Follicular non-Hodgkin's lymphoma full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing